The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I trial and pharmacokinetic (PK) study of satraplatin in children and young adults with refractory solid tumors including brain tumors.
Srivandana Akshintala
No relevant relationships to disclose
Leigh Marcus
No relevant relationships to disclose
Katherine E. Warren
No relevant relationships to disclose
Robert F. Murphy
No relevant relationships to disclose
Wendy J. Goodspeed
No relevant relationships to disclose
Anne Goodwin
No relevant relationships to disclose
Carmen C. Brewer
No relevant relationships to disclose
Christopher Zalewski
No relevant relationships to disclose
Kelly A. King
No relevant relationships to disclose
AeRang Kim
No relevant relationships to disclose
Brigitte C. Widemann
No relevant relationships to disclose